| 摘要 |
［Objectives］ To observe the clinical efficacy of Mongolian medicine silver needle combined with cupping and bloodletting therapy in the treatment of cervical spondylotic radiculopathy (CSR). [Methods] A total of 120 patients diagnosed with CSR who received treatment at the International Mongolian Hospital of Inner Mongolia between October 2021 and October 2022 were selected and randomly divided into two groups: A test group and a control group, with 60 patients in each group. The patients in the test group received Mongolian medicine silver needle combined with cupping and bloodletting therapy, following the principles of syndrome differentiation in Mongolian medicine. In contrast, the patients in the control group received only the Mongolian medicine silver needle therapy. After treatment, the Mongolian medicine syndrome scores, visual analogue scale (VAS) scores, and total clinical therapeutic effects in the two groups of patients were compared both prior to and following the treatment. [Results] The improvement in VAS and Mongolian medicine syndrome scores in the test group was greater than that in the control group, with a statistically significant difference (P<0.05). The scores of the test group surpassed those of the control group, and this difference was also statistically significant (P<0.05). Furthermore, the overall therapeutic effect in the test group was 93.33%, which was markedly higher than 76.67% observed in the control group (P<0.05). [Conclusions] The therapeutic effect of Mongolian medicine silver needle combined with cupping and bloodletting therapy in the treatment of CSR is remarkable. This approach has demonstrated efficacy in alleviating patient pain and improving the functionality of the cervical vertebrae, thereby warranting clinical promotion and application. |
